Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 6
Submit an article Journal homepage
999
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom

Melissa ThompsonCornerstone Research Group Inc. Burlington, ONCanadaCorrespondence[email protected]
,
Susan Bartko-WintersCornerstone Research Group Inc. Burlington, ONCanada
,
Lisa BernardCornerstone Research Group Inc. Burlington, ONCanada
,
Andy FentonGenzyme Therapeutics OxfordUK
,
Colin HutchisonUniversity of Birmingham and University Hospital Birmingham Edgbaston, BirminghamUK
&
Biagio Di IorioNephrology, ‘A. Landolfi’ Hospital Solofra (AV)Italy
Pages 744-755 | Accepted 28 Mar 2013, Published online: 17 Apr 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shahrzad Ossareh. (2014) Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients. International Journal of Nephrology and Renovascular Disease 7, pages 161-168.
Read now
Sushant Ramdas Taksande & Elaine M Worcester. (2014) Calcium supplementation in chronic kidney disease. Expert Opinion on Drug Safety 13:9, pages 1175-1185.
Read now

Articles from other publishers (12)

Kamolpat Chaiyakittisopon, Oraluck Pattanaprateep, Narisa Ruenroengbun, Tunlanut Sapankaew, Atiporn Ingsathit, Gareth J. Mckay, John Attia & Ammarin Thakkinstian. (2021) Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations. The European Journal of Health Economics 22:4, pages 571-584.
Crossref
Daniel M. Sugrue, Thomas Ward, Sukhvir Rai, Phil McEwan & Heleen G. M. van Haalen. (2019) Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design. PharmacoEconomics 37:12, pages 1451-1468.
Crossref
B. L. Goh, A. Soraya, A. Goh & K. L. Ang. (2018) Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders. International Journal of Nephrology 2018, pages 1-7.
Crossref
Marinella Ruospo, Suetonia C Palmer, Patrizia Natale, Jonathan C Craig, Mariacristina Vecchio, Grahame J Elder & Giovanni FM Strippoli. (2018) Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database of Systematic Reviews 2018:8.
Crossref
Raymond Vanholder, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodriguez & Alberto Ortiz. (2018) Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). Toxins 10:6, pages 237.
Crossref
Peter S Hall, Elizabeth D Mitchell, Alison F Smith, David A Cairns, Michael Messenger, Michelle Hutchinson, Judy Wright, Karen Vinall-Collier, Claire Corps, Patrick Hamilton, David Meads & Andrew Lewington. (2018) The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation. Health Technology Assessment 22:32, pages 1-274.
Crossref
Steven Habbous, Sebastian Przech, Janet Martin, Amit X. Garg & Sisira Sarma. (2018) Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease. Value in Health 21:3, pages 318-325.
Crossref
Wendy L. St. Peter, Lori D. Wazny, Eric Weinhandl, Katie E. Cardone & Joanna Q. Hudson. (2017) A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?. Drugs 77:11, pages 1155-1186.
Crossref
Rana Rizk. (2016) Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go. BMC Nephrology 17:1.
Crossref
María Dolores del Pino, Ramón Pons, Ana Rodríguez-Carmona, Marta Rubio Liria & Rudi Subirà. (2016) Análisis coste-efectividad de sevelámero frente a carbonato cálcico en pacientes con enfermedad renal crónica no dependientes de diálisis en España. PharmacoEconomics Spanish Research Articles 13:2, pages 49-56.
Crossref
Caroline M. Perry & Greg L. Plosker. (2014) Sevelamer Carbonate: A Review in Hyperphosphataemia in Adults with Chronic Kidney Disease. Drugs 74:7, pages 771-792.
Crossref
Shunsuke Goto, Hirotaka Komaba, Masafumi Fukagawa & Shinichi Nishi. (2013) Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder. Kidney International Supplements 3:5, pages 457-461.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.